Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer

Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer

To date, extensive efforts to harness immunotherapeutic strategies for the treatment of pancreatic ductal adenocarcinoma (PDAC) have yielded disappointing results in clinical trials. These strategies mainly focused on cancer vaccines and immune checkpoint inhibitors alone or in combination with chem...

Full description

Bibliographic Details
Main Authors:	Anna Maxi Wandmacher, Anne Letsch, Susanne Sebens
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Cancers
Subjects:	PDAC immunosuppression tumour microenvironment cancer vaccine checkpoint inhibition translational research
Online Access:	https://www.mdpi.com/2072-6694/13/16/4235

Similar Items

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
by: Jingchang Zhang, et al.
Published: (2022-07-01)

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
by: Group Young Researchers in Inflammatory Carcinogenesis, et al.
Published: (2021-09-01)

Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
by: Songyu Guo, et al.
Published: (2024-03-01)

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
by: Charlotte Kayser, et al.
Published: (2023-08-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
by: Anne M. Macpherson, et al.
Published: (2020-09-01)

Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment
by: Paula Dobosz, et al.
Published: (2022-03-01)

Sonic Hedgehog Ligand: A Role in Formation of a Mesenchymal Niche in Human Pancreatic Ductal Adenocarcinoma
by: Francesca Saini, et al.
Published: (2019-05-01)

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective
by: Suzy M. Scholl
Published: (2014-11-01)

Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance
by: Minglei Yang, et al.
Published: (2022-07-01)

Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives
by: Ilaria Salvato, et al.
Published: (2024-03-01)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
by: Yan Li, et al.
Published: (2022-01-01)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
by: Jesse D. Armitage, et al.
Published: (2021-01-01)

A Comparative Analysis of Orthotopic and Subcutaneous Pancreatic Tumour Models: Tumour Microenvironment and Drug Delivery
by: Jessica Lage Fernandez, et al.
Published: (2023-11-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
by: Tina Daunke, et al.
Published: (2023-06-01)

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Adam S. Bryce, et al.
Published: (2022-10-01)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01)

High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
by: Hassan Sadozai, et al.
Published: (2024-03-01)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
by: Wayne Croft, et al.
Published: (2023-06-01)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
by: Alexandros Bokas, et al.
Published: (2020-02-01)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
by: Benjamin M. MacCurtain, et al.
Published: (2021-06-01)

Tumor immunotherapy: Mechanisms and clinical applications
by: Cheng Nong, et al.
Published: (2022-06-01)

Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
by: Friederike V. Opitz, et al.
Published: (2021-12-01)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
by: Christian A. Linares, et al.
Published: (2023-08-01)

Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
by: Yunwei Yang, et al.
Published: (2024-02-01)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
by: Tsubasa Miyazaki, et al.
Published: (2020-07-01)

Staging Computed Tomography Parameters Predict the Need for Vein Resection during Pancreaticoduodenectomy in Resectable Pancreatic Ductal Adenocarcinoma
by: Rupaly Pande, et al.
Published: (2024-01-01)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
by: Evangelos Koustas, et al.
Published: (2022-06-01)

Progress in Immunotherapy for Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2014-01-01)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
by: Yangyang Guo, et al.
Published: (2023-06-01)

Neutrophils: New Critical Regulators of Glioma
by: Guanyu Wang, et al.
Published: (2022-07-01)

Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01)

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets
by: Emilie Alard, et al.
Published: (2020-07-01)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
by: Hongkai Zhuang, et al.
Published: (2021-12-01)

Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
by: Aaron Galindo-Vega, et al.
Published: (2023-06-01)

Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies
by: Kinga B. Stopa, et al.
Published: (2020-05-01)

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
by: Paolo A. Ascierto, et al.
Published: (2023-07-01)

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
by: Paolo A. Ascierto, et al.
Published: (2022-06-01)